Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for metabolic reprogramming of myeloid cells and anti-tumor effects
Takenori Uehara(Okayama University), Heiichiro Udono(Okayama University), Shingo Eikawa(Okayama University), Yuki Kunisada(Okayama University), Tomohiro Fujiwara(Okayama University), Mikako Nishida(Okayama University), Toshifumi Ozaki(Okayama University), Aki Yoshida(Okayama University), Toshiyuki Kunisada(Okayama University Hospital)
Cited by 118
Related Papers
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|343
Osteosarcoma of the spine
|Cancer|2002|282
Percutaneous radiofrequency ablation in osteoid osteoma
|Journal of Bone and Joint Surgery - British Volume|2001|267
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment
|Molecular Cancer Therapeutics|2021|258
Tumors of the pelvis: complications after reconstruction
|Archives of Orthopaedic and Trauma Surgery|2003|211